INZY
Price
$4.00
Change
-$0.09 (-2.20%)
Updated
Nov 8, 03:26 PM (EDT)
132 days until earnings call
OKYO
Price
$1.14
Change
+$0.01 (+0.88%)
Updated
Nov 8, 03:18 PM (EDT)
21 days until earnings call
Ad is loading...

INZY vs OKYO

Header iconINZY vs OKYO Comparison
Open Charts INZY vs OKYOBanner chart's image
Inozyme Pharma
Price$4.00
Change-$0.09 (-2.20%)
Volume$437
CapitalizationN/A
OKYO Pharma
Price$1.14
Change+$0.01 (+0.88%)
Volume$1.9K
CapitalizationN/A
View a ticker or compare two or three
INZY vs OKYO Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INZY vs. OKYO commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a StrongSell and OKYO is a Hold.

COMPARISON
Comparison
Nov 08, 2024
Stock price -- (INZY: $4.10 vs. OKYO: $1.13)
Brand notoriety: INZY and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 218% vs. OKYO: 48%
Market capitalization -- INZY: $283.83M vs. OKYO: $38.24M
INZY [@Biotechnology] is valued at $283.83M. OKYO’s [@Biotechnology] market capitalization is $38.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than OKYO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while OKYO’s TA Score has 5 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 7 bearish.
  • OKYO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OKYO is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а -4.43% price change this week, while OKYO (@Biotechnology) price change was -4.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +11.55%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

OKYO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($284M) has a higher market cap than OKYO($38.2M). INZY YTD gains are higher at: -3.756 vs. OKYO (-36.158).
INZYOKYOINZY / OKYO
Capitalization284M38.2M743%
EBITDA-82.82MN/A-
Gain YTD-3.756-36.15810%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash145MN/A-
Total Debt46.7MN/A-
TECHNICAL ANALYSIS
Technical Analysis
INZYOKYO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTIX30.990.30
+0.98%
Artisan International Investor
FIKLX9.530.09
+0.95%
Fidelity Advisor Intl Real Estate Z
SCWCX57.660.36
+0.63%
American Funds SMALLCAP World C
GARJX9.90N/A
N/A
Goldman Sachs Global Rl Estt Secs Inv
MMQIX9.22N/A
N/A
MassMutual Small Cap Val Eq I

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.07%
BEAM - INZY
59%
Loosely correlated
-1.99%
NTLA - INZY
50%
Loosely correlated
-0.37%
FATE - INZY
50%
Loosely correlated
-8.60%
DNLI - INZY
50%
Loosely correlated
+0.17%
AVIR - INZY
49%
Loosely correlated
-3.91%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and MEIP have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and MEIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+0.89%
MEIP - OKYO
24%
Poorly correlated
-0.33%
CLNN - OKYO
24%
Poorly correlated
+2.97%
AKBA - OKYO
23%
Poorly correlated
-6.75%
URGN - OKYO
22%
Poorly correlated
-1.14%
INZY - OKYO
22%
Poorly correlated
-3.07%
More